Oculenz™ AR Glasses Garners Important Medical Support for Restoring Functional Sight to Patients with Visual Field Deficits
Irvine, Calif. (April 2, 2019)
Ocutrx Vision Technologies, LLC, a California based Augmented Reality (AR) Glasses developer today announced that Dr. Thomas A. Finley, M.D. will serve as the Chairman of the Ocutrx International Medical Advisory Board (IMAB). The Board serves to advise Ocutrx in its development of Augmented Reality glasses for medical use for helping patients with Age-related Macular Degeneration (AMD) and other visual field defects.
“Dr. Finley is an exceptional vitreoretinal surgeon and ophthalmic medical professional with a broad vision and perspective in the application of new technologies for improving patient outcomes,” said Michael H. Freeman founder and CEO of Ocutrx. “Most importantly, he is a proven administrator with powerful leadership skills; and we are honored to have him serve our IMAB team as Chairman to help get our technology out to the medical community.”
“I greatly appreciate the opportunity to be so intimately involved in the development and research of the Oculenz AR headwear,” said Dr. Finley. “It’s exciting to be a part of a team that developing a solution for patients with central visual defects which potentially restores to them a life of activity they once thought was gone forever. Ocutrx has assembled a wonderful team of medical advisors with a wealth of experience in treating advanced eye disease.”
Dr. Finley graduated from the University of Oklahoma College of Medicine, completed his residency training at the University of Alabama at Birmingham, and his vitreoretinal fellowship with Retina Consultants of Alabama/UAB. Dr. Finley was board certified in ophthalmology in 2011. In 2015, Dr. Finley and his physician business partner, Dr. Lars Freisberg, M.D came together to create Tulsa Retina Consultants, a Mid-Western reginal ophthalmic-care clinic. Today, Tulsa Retina Consultants is one of the region’s largest and fastest growing group of retina specialists. Both Dr. Finley and Dr. Freisberg are named as co-inventors along with the company’s engineers on the new AR/AMD diagnostic-mode technologies in patent applications of Ocutrx.
Other Ocutrx IMAB board members include the following: Dr. Lars Freisberg. M.D. who is an ophthalmologist with Tulsa Retina Consultants and is board certified in Ophthalmology in the United States, Germany and Norway; Dr. Sam Garg, who is the Assistant Clinical Professor at the Department of Ophthalmology, Gavin Herbert Eye Institute, University of California-Irvine (UCI), Medical Director at the Gavin Herbert Eye Institute, and Vice-Chair of Clinical Ophthalmology at the Department of Ophthalmology UCI; Dr. Linda Lam, M.D. who serves as the Vice-Chair of Satellite Clinical Affairs and Director, USC Eye Institute Arcadia, and an Associate Professor in Ophthalmology at the Keck School of Medicine at USC; Dr. Diane Whitaker, O.D., who is the Division Chief of Vision Rehabilitation and Performance at Duke University Eye Center, Assistant Professor of Ophthalmology, Duke School of Medicine, and Clinical Program Director, Duke Sports Vision Center; Dr. Robert W. Crow, M.D. who is a Neural Ophthalmologist and Assistant Professor of Neuro-Ophthalmology at the Gavin Herbert Institute of UCI; and Dr. Patrick Yoshinaga, O.D., M.P.H., F.A.A.O. who is an Associate Professor at Southern California College of Optometry and is a Fellow with the American Academy of Ophthalmology.
About Ocutrx
With corporate headquarters in Irvine, California, and a R&D lab in the Midwest, Ocutrx is a new breed of AR company. The company’s Augmented Reality headset, called Oculenz™ boasts the widest field-of-vision in the industry, with a 110-degree high-resolution heads-up display, in a wirelessly connected, untethered, micro-weight headset with eye-tracking. Ocutrx was founded in 2015 by Michael H. Freeman, a two-time 1994 Emmy award-winning designer of the first cellular streaming video technology which was later purchased by Samsung.